Proneural proteins of the class I/II basic-helix-loop-helix (bHLH) family are transcription factors that are highly conserved from invertebrates to humans. Class I bHLH proteins are expressed in a broad number of tissues during development, while class II bHLH protein expression is more tissue restricted. The current understanding of the function of class I/II bHLH transcription factors in both invertebrate and vertebrate neurobiology is largely focused on their function as master regulators of embryonic neurogenesis. Now, a study from researchers at Drexel University shows that Transcription Factor 4 (TCF4), a human class I bHLH protein, remains present in cells after neurogenesis where they turn jobless cells into neurons. The team state that their discovery that a particular protein give cells a job and also sticks around to tell them how to do these new assignments could provide insight into schizophrenia. The opensource study is published in the journal Cell Reports.
Previous studies show that mutations in TCF4 have been reliably identified in genome-wide association studies as a susceptibility risk factor for schizophrenia. However, it is unknown whether this disease is due to defects in neurogenesis, in mature differentiated cells, or both. Literature suggests that disrupted neurogenesis and/or neural differentiation may be partly responsible. For example, TCF4 is expressed widely in the nervous system during mouse embryonic development and is also expressed in germinal layers of the postnatal mouse brain. Therefore, it has been suggested that schizophrenia and other neurocognitive disorders may also be a result of dysfunction in postmitotic/differentiated neurons. The current study analyzes the effect of altering TCF4 using a mouse model to further understand the contributions of type I bHLH proteins in postmitotic neurons after neurodevelopment.
The current study shows in a mouse model that TCF4 is present in mouse brain postmitotic neurons, and that mouse TCF4 also functions to restrict neurite branching/synaptogenesis. Results show that not only do the proteins take a cell that doesn’t have a job and give it one, it also tells that cell how to do it. Data findings show that TCF4 also regulates the number of synapses in neurons, it had not disappeared and was still present and very active.
The lab state that these findings are particularly important because of the association TCF4 gene variants have with schizophrenia and Pitt-Hopkins Syndrome, a neurodevelopmental disorder. They go on to add that as mutations in TCF4 are associated with both diseases they hypothesize that TCF4 is most likely involved in helping to form the proper number of synapses a cell makes, so that the information flow in the nervous system doesn’t get confused and dysfunctional. The researchers conclude that when a patient loses these proteins, they suddenly get too many synapses which disrupts the nervous system function.
The team surmise that their findings suggest that depending on the severity of the mutation’s effect on TCF4, there may be differing outcomes. They go on to add that too severe a mutation may cause a strong effect like Pitt-Hopkins Syndrome, while other changes in the gene may increase the risk of schizophrenia. For the future, the researchers state that further study of the presence of TCF4 in neurons could uncover more about the relationship between synapse number and adult nervous system function, as well as autism.
Source: Drexel University
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.